Silexion Therapeutics Corp
Silexion Therapeutics Corp (SLXN): 2 pipeline candidates · ~2 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
2.4 months
D/E 14.81 · 3% dilution
Lead: Phase 2/Phase 3
2 candidates
N/A
0 buys · 1 sell (180d)
A transparent, data-derived signal for Silexion Therapeutics Corpacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$2.7M
Cash
$2.5M
Quarterly Burn
$3.6M
Runway
2.4 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| sig12d-loder | Phase 2 |
| sil204 | Phase 2/Phase 3 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
4
Total value held
$46K
| Holder | Shares | Value |
|---|---|---|
| citadel advisors llc | 20,926 | $27K |
| two sigma securities, llc | 11,657 | $15K |
| montag a & associates inc | 3,000 | $4K |
| jones financial companies lllp | 26 | $32 |
Frequently asked questions
How many drug candidates are in Silexion Therapeutics Corp's pipeline?
Silexion Therapeutics Corp (SLXN) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Silexion Therapeutics Corp's lead drug candidate?
Silexion Therapeutics Corp's most advanced tracked candidate is sig12d-loder (Phase 2) for Non-resectable locally advanced pancreatic cancer (LAPC).
What is Silexion Therapeutics Corp's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Silexion Therapeutics Corp has approximately 2.4 months of cash runway.
What is Silexion Therapeutics Corp's market capitalization?
Silexion Therapeutics Corp's market capitalization is approximately $2.7M.
Who is the CEO of Silexion Therapeutics Corp?
Mr. Ilan Hadar M.B.A. is the chief executive officer of Silexion Therapeutics Corp (SLXN).
Get the full picture on Silexion Therapeutics Corp
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.